Skip to main content

GCE4All Center Certified Protocols

GCE4All Center Certified Protocols

  • These protocols have been tested by the GCE4All Research Center and resources needed for the protocols are generally available through Addgene.
  • These protocols are reliable and robust for expressing the sfGFP florescence reporter protein with the relevant non-canonical amino acid (ncAA) incorporated at position 150 (sfGFP-150-ncAA).
  • Confirming sfGFP-150-ncAA expression at near stated yields is recommended as the first step for anyone seeking to use the protocol; then sfGFP-150-ncAA expression can always be used as a control for the process.
  • Every protein of interest (POI) to be expressed will have unique characteristics, and thus optimized expression of a given POI may require modifications of the protocol.
  • For help with protocol implementation and troubleshooting, as well as experimental design, please join the GCE bulletin Board list-serve and post your questions/requests there to access support from members of the GCE4All Research Center and the broader GCE community.

Protocols

GCE4All-1: For expression in E. coli of proteins containing phosphoserine

Citation: Zhu P, Mehl RA, Cooley RB (2022) Site-specific Incorporation of Phosphoserine into Recombinant Proteins in Escherichia coli. Bio-protocol 12:e4541. doi: 10.21769/BioProtoc.45.

Notes:

A method is also published for using this GCE system to make 13C-, 15N-isotopically labeled proteins containing phosphoserine such as would be useful for NMR studies. The expression methods for isotopic labeling of pSer proteins are different than for standard expressions because the ∆serB expression hosts are serine auxotrophs and therefore cannot grow in conventional minimal media.

GCE4All-2: For expression in E. coli of proteins containing non-hydrolyzable phosphoserine (the “Permaphos” system)

Citation: Zhu P, Mehl RA, Cooley RB (2023) Biosynthesis and Genetic Encoding of Non-hydrolyzable Phosphoserine into Recombinant Proteins in Escherichia Coli. Bio-protocol 13: e4861. DOI: 10.21769/BioProtoc.4861.